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Abstract
Background: Cloning vectors capable of retroviral transduction have enabled stable gene overexpression in
numerous mitotic cell lines. However, the relatively small number of feasible restriction enzyme sequences in their
cloning sites can hinder successful generation of overexpression constructs if these sequences are also present in
the target cDNA insert.
Results: Utilizing ligation-independent cloning (LIC) technology, we have modified the highly efficient retroviral
transduction vector, pBABE, to eliminate reliance on restriction enzymes for cloning. Instead, the modified plasmid,
pBLIC, utilizes random 12/13-base overhangs generated by T4 DNA polymerase 3’ exonuclease activity. PCR-based
introduction of the complementary sequence into any cDNA of interest enables universal cloning into pBLIC. Here
we describe creation of the pBLIC plasmid, and demonstrate successful cloning and protein overexpression from
three different cDNAs, Bax, catalase, and p53 through transduction into the human prostate cancer cell line, LNCaP
or the human lung cancer line, H358.
Conclusions: Our results show that pBLIC vector retains the high transduction efficiency of the original pBABE
while eliminating the requirement for checking individual cDNA inserts for internal restriction sites. Thus it
comprises an effective retroviral cloning system for laboratory-scale stable gene overexpression or for high-
throughput applications such as creation of retroviral cDNA libraries. To our knowledge, pBLIC is the first LIC vector
for retroviral transduction-mediated stable gene expression in mammalian cells.
Background
Cloning vectors capable of being packaged into retro-
viral particles for transduction into mammalian cells
provide efficient tools for stably altering the genome of
dividing cells. In this regard, the Moloney murine leuke-
mia virus (MMLV)-based pBABE vector system [1] has
been widely utilized for highly efficient stable gene over-
expression in a variety of different mammalian cells
with negligible off-target cellular effects. The pBABE
vector consists of a bacterial origin of replication, viral
elements for gene packaging, transcription and proces-
sing, and a unique restriction enzyme sequence-based
cloning site http://www.addgene.org/1767/. Additionally
it contains an ampicillin-resistance gene for selection in
bacteria, and either puromycin, hygromycin or neomycin
(G418)- resistance genes in order to select for stably
transduced cell lines [1]. This is the first retroviral trans-
duction system that does not require helper viruses.
Instead either amphotropic or ecotropic viral env gene-
expressing and gag-pol gene-expressing plasmids are co-
transfected along with the desired pBABE construct into
an appropriate packaging cell line to produce high-titer,
replication-incompetent viruses for the transfer and
expression of exogenous genes in mammalian cells [1].
The ability to use pBABE constructs as part of a three-
plasmid packaging system greatly reduces the probability
of recombination events leading to horizontal transfer
and live virus production in the transduced lines, mak-
ing it a safe and effective retroviral gene transduction
system.
A major disadvantage of the pBABE plasmid is its
relatively limited cloning site http://www.addgene.org/
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enzymes need to be selected from the cloning site so as
to generate non-complementary overhangs in the
digested DNA, thus preventing self-ligation. When such
a double digestion protocol is used, a series of conditions
must be taken into consideration. Besides the absence of
each enzyme site in the target DNA, the two enzymes
should share a common set of optimal reaction condi-
tions, including salt concentrations, digestion times and
activation/inactivation temperatures. Lack of such com-
patible digestion conditions necessitates tedious and
time-consuming sequential digestions as well as loss of
DNA product during intermediate purifications. The
enzymes that best fit these criteria in the pBABE multiple
cloning site are SalI, BamHI and EcoRI. In our experience
[2,3], using SalI does not uniformly yield optimal diges-
tion in combination with either BamHI or EcoRI, leading
to reduced cloning efficiency. Additionally if any of these
three sites, particularly BamHI or EcoRI, are internally
present within the target cDNA, then the cloning process
becomes extremely complicated.
Ligation-independent cloning (LIC) technology was
developed to remove the conventional requirements of
compatible restriction enzyme sites and exogenous enzy-
matic ligation during the cloning process [4]. This meth-
odology has been used for PCR-based amplification of
genomic DNA sequences [4], to generate vectors for
bacterial protein overexpression [5], for high-throughput
cloning of biocatalysts from prokaryotic genomes [6],
for the addition of variable-length C-terminal histidine
tags [7], and for gene silencing in plant cells [8]. How-
ever to our knowledge, there are no LIC retroviral vec-
tors available for stably overexpressing proteins in
mammalian cells.
Therefore, to increase cloning applicability and effi-
ciency, we adapted the pBABE retroviral plasmid back-
bone into a LIC version denoted as pBLIC (Additional
File 1, Figure S1). Unlike pBABE, cloning into this vec-
tor no longer requires conventional restriction site-gen-
erated sticky ends but instead relies on a random 12/13-
sequence comprised of 3 bases. The 12/13-mer
sequences are designed such that overhangs are gener-
ated using the 3’ exonuclease activity of T4 polymerase.
The complementary overhang sequence can be added to
target cDNA inserts via PCR extension from a primer
template. Because the overhang is generated by exonu-
clease rather than endonuclease activity and requires a
free 3’ end, it will not be processed even if it does hap-
pen to be internally present in the target cDNA.
Here we outline the strategy we followed to modify the
pBABE plasmid vector into pBLIC. We demonstrate suc-
cessful cloning of three different cDNA for proteins of
different molecular weights, Bax (MW: 26 kDa), catalase
(MW: 60 kDa) and p53 (MW: 53 kDa) into the adapted
vector, and protein overexpression from the transduced
constructs in the LNCaP human prostate cancer cell line.
Thus our results support wide applicability of the modi-
fied pBLIC plasmid for mammalian retroviral transduc-
tion and protein overexpression without consideration of
restriction enzymes sites or prior ligation during the
cloning process. The rationale behind our basic protocol
can be readily used to adapt other retroviral plasmids.
Thus our method provides an easy and rapid universal
method of introducing any DNA sequence of interest
into the modified LIC retroviral vector, enhancing the
efficiency of laboratory-scale cloning. Further the LIC
retroviral system can greatly facilitate high-throughput
cloning processes such as those used for the creation and
verification of retroviral gene overexpression libraries
where screening individual inserts for internal restriction
enzyme sites is impractical.
Results and Discussion
The goal of our study was to convert the pBABE retro-
viral vector into an LIC version in order to remove the
requirement for screening target cDNA inserts for
absence of desired cloning restriction enzyme sites and
for more universally efficient cloning. Eliminating
restriction enzymes from the cloning process necessi-
tates utilizing another means of generating complemen-
tary DNA overhangs in the plasmid and target insert.
This was achieved by using the 3’ exonuclease activity of
T4 DNA polymerase and site-specifically inhibiting the
competing 5’ polymerase activity by leaving out a subset
of deoxynucleotides from the reaction mixture, a techni-
que that has been previously used to generate LIC vec-
tors [4]. The adaptor module added to convert pBABE
into pBLIC (Figure 1) was designed to facilitate this
manner of overhang generation. Therefore it involved
three elements: the addition of a blunt cutter enzyme
site not present in the original plasmid, restriction
enzyme sites corresponding to the cloning site in
pBABE to allow ligation of the adaptor insert, and 12/
13-mer sequences consisting of three randomly repeated
bases (excluding the base corresponding to the added
deoxynucleotide) that would constitute the overhang.
The first step involved identifying a blunt cutter
enzyme not present in the pBABE plasmid. Accordingly,
we added a PmlI consensus sequence into the adaptor
insert (Figure 1). Thus once the adaptor was successfully
inserted into the pBABE backbone, digestion with PmlI
yielded the linearized plasmid for the pBLIC version but
not for the original pBABE version (Figure 2A). The lin-
earized form acts as a template for T4 exonuclease
activity.
For the sequence overhangs generated upstream of the
PmlI digestion site (Figure 1), we used a random combi-
nation of A, T and C such that it was unlikely to
Patel et al. BMC Biotechnology 2012, 12:3
http://www.biomedcentral.com/1472-6750/12/3
Page 2 of 9correspond to a restriction enzyme site or coding DNA.
The overhang was maintained by leaving out dCTP,
dATP and dTTP from the reaction mixture, thus inhi-
biting T4 5’ DNA polymerase activity from filling in the
overhang. Conversely, digestion past the desired over-
hang sequence (Figure 1) was prevented by addition of
dGTP to the reaction mixture, allowing polymerase
activity to proceed as soon as the bold italicized G in
the adaptor sequence is encountered (Figure 1). The
choice of which three bases to be used to generate the
random overhang is dependent on the three bases 5’ of
digestion site in the restriction sequence of the single
cutter enzyme. For instance the restriction sequence for
PmlI is CAC-GTG, where the hyphen denotes the diges-
tion site that leads to the blunt 3’ end. Thus C and A
were necessarily included in the pBLIC adaptor
sequence (Figure 1).
Finally we added SalI and BamHI overhang sequences
to the ends of the adaptor module (Figure 1). Note that
only the overhang sequences that are generated via
restriction digestion (as opposed to the full palindromic
consensus sequence) were added. The pBABE plasmid
was digested with these two enzymes in order to remove
its original cloning site and to permit ligation of the
adaptor insert into the plasmid to generate pBLIC. This
process restored the full BamHI site but the palindromic
nature of the SalI site was destroyed (Figure 1).
Conversion of the pBABE plasmid into pBLIC was
also confirmed by digestion with PmlI. Subsequent to
PmlI digestion, as expected in the pBABE plasmid, the
gel exhibited bands corresponding to the fully intact,
nicked and linearized forms of the plasmids (Figure 2A).
In contrast, the vector with the ligated LIC insert
showed a single band corresponding to a linearized ~5
Figure 1 Schematic depicting the conversion of the pBABE-Neo plasmid into pBLIC-Neo by insertion of a specially designed LIC
adaptor. The LIC adaptor consists of a PmlI site and a 12/13 base pair sequence used for LIC cloning (for generating overhangs consisting of 13
bases on the left side and 12 bases on the right). The PmlI restriction sequence is bolded and the digestion site is indicated by an inverted
triangle within the restriction sequence. The terminal overhang sequences for BamHI (right) and SalI (left) that allow ligation of the LIC adaptor
into the original pBABE-Neo plasmid are italicized. Note that the palindromic nature of the SalI site (G/TCGAC) will be lost upon ligation of the
adaptor sequence with the digested pBabe plasmid (CTCGAC). The guanines that serve as T4 exonuclease activity termination sites are bolded
and italicized.
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the digested pBABE plasmid destroys the SalI unique
cloning site present in the original plasmid. Accordingly,
when both pBABE and pBLIC were digested with SalI,
pBLIC no longer yielded the linearized band (Figure
2B). Finally insertion of the LIC adaptor was verified by
sequencing with the SV40 promoter reverse primer 5’
GAAATTTGTGATGCTATTGC 3’.
Once we verified conversion of pBABE to the pBLIC
version, we wanted to validate its ability to be used as a
gene overexpression vector that can be virally packaged
and transduced in mammalian cells. To do so, we used
the pBLIC vector to clone three cDNA constructs that
are of interest to our laboratory, the pro-apoptotic pro-
tein Bax, the antioxidant protein, catalase and the
tumor suppressor/DNA damage-responsive protein, p53.
These had previously proved difficult to clone into the
pBABE vector due to the presence of internal BamHI
and/or EcoRI sites in their cDNA sequences. As
described in the Methods section and outlined above,
PCR primers were designed to add 12/13-mer
sequences complementary to the T4-generated pBLIC
overhangs (Figure 1) to the cDNA to allow ligation of
the plasmid and insert. This was accomplished by PCR
elongation from the appropriate primer template (Table
1). The resulting duplex segment was treated with T4
polymerase, with only dCTP added to the reaction mix-
ture, in order to produce complementary overhangs.
The co-mixed insert and plasmid (as described in Meth-
ods) were used to transform XL-10 gold recombination-
deficient E. coli, and ligation was accomplished endo-
genously by the bacterial DNA repair enzymatic
Figure 2 Verification of LIC adaptor sequence insertion into the pBABE-Neo plasmid. (A) PmlI enzyme-treated and untreated versions of
both pBABE and pBLIC plasmids were run on a 0.7% agarose gel to check for insertion of the adaptor via presence of a PmlI site. A 1 kb ladder
(NEB, N3232S) is used to mark band sizes. Gels were photographed on a Canon Powershot G10 mounted on a UVP Multidoc-it Digital Imaging
System using standard preset contrast settings. Note that for the digested pBLIC, a single band corresponding to the linearized plasmid (~ 5 kb)
is observed whereas the treated pBABE plasmid yields the same set of bands as the undigested plasmid. (B) Both pBABE and pBLIC were
digested with SalI to check for loss of its restriction site, as expected upon successful insertion of the LIC adaptor sequence. For pBABE, a single
band corresponding to a linearized plasmid at ~ 5 kb is seen whereas for pBLIC, the super-coiled and nicked forms are observed, indicating lack
of digestion.
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bacterial pellets and were verified both by internal
digestion at a unique HindIII site to yield a fragment of
lower mobility containing the insert (Figure 3A-C) rela-
tive to the empty vector as well as by DNA sequencing
(Additional File 1, Figure S2).
The purified pBLIC cDNA constructs were used to
transduce the human prostate cancer cell line LNCaP,
as described in Methods. The modified construct
appeared to be as efficiently packaged into viral parti-
cles as the parental pBABE plasmid judging by the
lysed appearance of the packaging HEK 293T cells (not
shown). The transduced cells were continuously
selected in G418-containing media. Mock-transduced
LNCaP cells were used as a “canary” plate - all cells in
this plate died within a week whereas approximately
20% cells died in the transduced plates within the
same time period. Subsequently cells showed minimal
death in G418-containing media, indicating that only
the successfully transduced cells had survived. Cells
harvested from the empty pBLIC-neo and pBLIC-Bax,
pBLIC-catalase or pBLIC-p53 transduced samples were
subjected to RT-PCR and Western blotting to deter-
mine expression of the target cDNA. Both Bax (Figure
4A) and catalase (Figure 4B) constructs showed robust
overexpression of the respective full-length mRNA and
Table 1 PCR primers for cloning into pBLIC
cDNA Primer Sequence
Bax Fwd: 5’
CACACCATCTCACGGCCACCATGGACGGGTCCGGGGAGCAG 3’
Rev: 5’ CTCACATTCCACGTCAGCCCATCTTCTTCCAGATG 3’
Catalase Fwd: 5’ CACACCATCTCACGGCCACCATGGCTGACAGCCGGG 3’
Rev: 5’ CTCACATTCCACGGGTGGCTCACAGATTTGCCTTCTC 3’
p53 Fwd: 5’
CACACCATCTCACGGCCACCATGGAGGAGCCGCAGTCAGATCC
3’
Rev: 5’ CTCACATTCCACGTCAGTCTGAGTCAGGCCCTTCTGT 3’
Overhang sequences are bolded, the T4 exonuclease activity termination site
guanine is bolded and italicized, and the Kozak sequence is underlined.
Figure 3 Verification of Bax, catalase or p53 cDNA insertion into pBLIC. Clones were digested with HindIII and run on a 0.7% agarose gel.
A 1 kb ladder is used to mark band sizes. Gels were photographed on a Canon Powershot G10 mounted on a UVP Multidoc-it Digital Imaging
System using standard preset contrast settings. The mobility shift relative to the empty pBLIC vector indicates presence of the cDNA insert.
Restriction digest products for (A) pBLIC-Bax, (B) pBLIC-catalase, and (C) pBLIC-p53 are shown. Note that the shift in HindIII-treated plasmids is
greater for catalase and p53 relative to Bax, corresponding to the larger insert size of the former two cDNAs relative to the latter (catalase: 1584
bp, p53: 1182 bp vs. Bax: 657 bp).
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the pBLIC-p53 construct yielded p53 mRNA overex-
pression in LNCaP cells (Figure 4C), we were unable
to detect significant p53 protein overexpression in
these cells (not shown). Because the transcript was
overexpressed and the LNCaP cells exhibited G418
resistance, we surmised that the excess p53 was being
post-translationally targeted for degradation by Mdm2
in the LNCaP cells, which possess a fully functional
p53 pathway [9]. Accordingly we also transduced the
pBLIC-p53 construct in the p53-null [10] H358 lung
cancer cell line. In this background, we were able to
detect a high degree of p53 protein overexpression
from pBLIC-p53 (Figure 4C).
Conclusions
In this study, we demonstrate successful conversion of
the pBABE retroviral transduction vector into an LIC
version, pBLIC. The pBLIC vector retains the highly effi-
cient transduction and overexpression capability of the
original pBABE with the added advantages of ligation-
independent cloning. Although we present here the
results demonstrating gene overexpression using the
converted pBABE plasmid with neomycin (G418) resis-
tance, we have also converted the pBABE-puromycin
plasmid by the same process (not shown). Furthermore
the general strategy outlined above can be easily utilized
to convert other retroviral plasmids such as pWZL,
pLXSN or pMIG into LIC versions. Given the popularity
Figure 4 Verification of pBLIC-Bax, pBLIC-catalase or pBLIC-p53 transduction and protein overexpression. Either LNCaP or H358 cells were
transduced with the indicated overexpression constructs and selected in G418-containing media as described in the Materials and Methods section, and
harvested within 7 days of selection. RT-PCR and Western blot analysis was used to confirm overexpression of mRNA and protein from the constructs. RT-
PCR and Western blotting was carried out on RNA and protein samples from cells transduced with the indicated constructs. Cells transduced with the
empty pBLIC-Neo vector were used to determine baseline levels of the two proteins. Single bands were seen corresponding to the full-length mRNA (top
panel, RT-PRCR) or protein (bottom panel, Western blotting) in all cases. GAPDH is shown as a loading control for both RT-PCR and Western blotting. (A)
Overexpression of Bax mRNA and protein from pBLIC-Bax in LNCaP cells. (B) Overexpression of catalase mRNA and protein from pBLIC-catalase in LNCaP
cells. (C) Overexpression of p53 mRNA in LNCaP cells and p53 protein in H358 cells from the pBLIC-p53 construct.
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transduction and overexpression of cDNAs, we believe
that the pBLIC version will simplify and extend its
applications, for instance by m a k i n gi taf e a s i b l ev e c t o r
for high-throughput cloning applications such as genera-
tion of cDNA libraries.
Methods
Cell culture
LNCaP cells were cultured in RPMI-1640 medium contain-
ing 5% fetal bovine serum and 100 units/ml penicillin-strep-
tomycin. H358 cells were cultured in RPMI-1640 in 10%
fetal bovine serum and 100 units/ml penicillin-streptomy-
cin. HEK-293T cells were cultured in Dulbecco’sM o d i f i e d
Eagle Medium (DMEM) containing 10% fetal bovine serum
and 100 units/ml penicillin-streptomycin. All cell culture
reagents were obtained from Gibco, Invitrogen.
Design of the LIC adaptor segment
The LIC segment was designed to contain SalI and
BamHI overhangs to allow ligation into the pBABE
cloning site. It also contained the following 12/13-mer
sequences to create overhangs via T4 exonuclease activ-
ity (13 base overhang on the left below, 12 base over-
hang on the right):
5’ GATCCGCACACCATCTCACGTGGAATGT-
GAGC3 ’
3’ GCGTGTGGTAGAGTGCACCTTACACTCGAGCT
5’
The bolded letters indicate the complementary SalI
and BamHI sites used to ligate the segment into the
pBABE backbone. The underlined site is for the unique
blunt cutter PmlI to generate the ends/starting site for
3’ T4 polymerase exonuclease activity. The 12/13-base
sticky ends generated by this activity are italicized.T h e
bold, italicized Gs are stopping points for T4 exonu-
clease activity. This is accomplished by adding only
dGTP to the reaction mixture. Thus the chemical equili-
brium for T4 polymerase shifts from the 3’-> 5’ exonu-
clease activity to the 5’-> 3’ polymerase activity only
once the italicized bolded G is encountered by T4 poly-
merase as the other complementary nucleotides to the
italicized overhang are absent. The above oligonucleo-
tides (Integrated DNA Technologies) were used to gen-
erate the adaptor segment by annealing in a 1:1 ratio (5
μlo f1μg/μl each in NEB Buffer 2).
Construction and preparation of the modified backbone
vector
The pBABE-neomycin vector was digested with BamHI
and SalI to remove the original cloning site and the
resulting segment was gel purified using the Qiagen
gel purification kit according to manufacturer instruc-
tions. The annealed LIC adaptor segment (described
above) was diluted 1:10 and mixed with 50 ng of the
purified digested pBABE vector prior to ligation using
a Rapid DNA ligation kit (Roche) as per manufac-
turer’s instructions. The resulting pBLIC plasmid was
digested with PmlI to generate the linearized plasmid.
This was subsequently treated with T4 polymerase
(NEB). Treatment conditions were as follows: 0.4 pmol
digested vector, 2 μl 10X Buffer 2 (NEB), 2 μld G T P
(Roche), 2 μl 100 μM dithiothreitol (DTT, Sigma), 0.4
μl T4 Polymerase (NEB). DNAse- and RNAse-free
water (Gibco, Invitrogen) was used to make up a total
volume of 20 μl. This solution was incubated at 22°C
for 40 minutes and then at 75°C for 20 minutes to
inactivate the T4 polymerase.
General primer design for cDNA of interest
In order to generate the cDNA fragment to be cloned
into the pBLIC backbone, the following PCR primer
design was utilized to contain complementary sequences
to the T4 exonuclease activity-generated overhangs in
pBLIC:
Sense: 5’ CACACCATCTCACG-GCCACC-the first 20
bases of cDNA starting with ATG
Antisense: 5’ CTCACATTCCACG-20 bases from the
3’ end of the cDNA
The italicized nucleotides in the forward primer corre-
s p o n dt ot h eK o z a ks e q u e n c e[ 1 1 ] ,t oi m p r o v et r a n s l a -
tional efficiency. For primers specific to Bax, catalase
and p53, see Table 1.
PCR amplification of insert and addition of
complementary overhangs
Samples for PCR amplification were made by adding 50 ng
of DNA, 1 μlo f1 0μM dNTP, 5 μL of 10X PCR buffer, 1.5
μl of 50 mM MgCl2,1μl each of forward and reverse pri-
mer at a 10 μM final concentration, 0.5 μl of Platinum taq
DNA polymerase (Invitrogen) and dH2Of o ra5 0μl final
reaction volume. Gradient PCR (Eppendorf) with anneal-
ing temperatures between 55-67°C and 35 cycles was used
for optimal primer extension. Unincorporated dNTPs
from the PCR samples were removed using a gel purifica-
tion kit (Qiagen). This was subsequently treated with T4
polymerase (NEB). Treatment conditions were as follows:
0. 2 pmol annealed DNA, 2 μl 10X Buffer 2 (NEB), 2 μl
dCTP (Roche), 1 μl1 0 0μMD T T ,0 . 4μlo fT 4P o l y m e r a s e
(NEB) and DNAse- and RNAse-free water (Gibco, Invitro-
gen) to make a total volume of 20 μl. This solution was
incubated at 22°C for 40 minutes and then at 75°C for 20
minutes to inactivate T4 polymerase.
Bacterial transformation and amplification of the pBLIC
cDNA retroviral mammalian construct
The T4-treated pBLIC construct (0.04 pmol) and cDNA
fragment (0.04 pmol) were mixed together using 1 μlo f
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minutes at 22°C. Instead of a ligation step, 1 μlo f2 5
mM EDTA was added to a final solution volume of 4 μl
for a further 5-minute incubation period to stabilize the
non-covalent interactions between the DNA backbone
and insert. Approximately 1 μl of this mixture was used
to transform recombination-deficient competent XL-10
Gold bacteria (Stratagene) and plated on ampicillin-agar
plates (final ampicillin concentration: 100 μg/ml). Com-
petent colonies were selected for inoculation in 100 μg/
ml ampicillin-containing LB media, and the resulting
DNA plasmid was purified using Qiagen DNA mini and
midi prep kits.
Verification of cloned construct by enzymatic treatment
and DNA sequencing
Purified cloned plasmids were analyzed for the appropri-
ate cDNA insert by digesting the constructs with Hin-
dIII to detect a shift in size equal to the size of Bax,
catalase or p53. Additionally, using sequencing primers
against pBABE (pBABE5’: CTTTATCCAGCCCTCAC /
pBABE3’: ACCCTAACTGACACACATTCC), constructs
were sequenced at the University of Miami Oncoge-
nomics Facility to verify that the target cDNAs were
present in the respective cloned pBLIC construct (Addi-
tional File 1, Figure S2).
Retroviral transduction of constructs
The pBLIC-Bax, pBLIC-catalase and pBLIC-p53 con-
structs were transduced as described previously [2,12]
into the LNCaP human prostate cancer cells or H358
human lung cancer cells. Briefly viral particles were pro-
duced by co-transfecting 3 μg MuLV gag-pol-expressing
plasmid pUMVC, 300 ng envelope protein-expressing
plasmid pCMV.VSV-G and 3-4 μg target construct into
HEK 293T cells. The transfection complex was pro-
duced in serum-free DMEM media via the transfection
agent Fugene
®6 (Roche) at Fugene (μl): total DNA (μg)
ratio of approximately 2:1. The viral supernatants from
293T cells were harvested at 48 hours and 72 hours and
applied to the LNCaP cells for 6-8 hours in the presence
of 6 μg/ml protamine sulfate. At 48 hours after the last
transduction, 500 μg/ml G418 was added to the cell cul-
ture media and to a mock-transduced plate of cells.
Cells were subsequently continuously selected in G418-
containing media to enrich for successfully transduced
cells.
Reverse-transcriptase PCR
Total RNA was isolated using the RNAqueous-4PCR Kit
(Ambion) as per manufacturer instructions. A total of
0.25 μg purified RNA was reverse-transcribed using a
random primer to obtain cDNA via the High Capacity
cDNA Reverse Transcription Kit (Applied Biosystems).
The cDNA was used as a template for PCR amplifica-
tion using AmpliTaq Gold
® 360 Master Mix (Applied
Biosystems) via the primers listed in Table 2. The reac-
tions were run on a 1.5% agarose gel and bands were
visualized by ethidium bromide staining. GAPDH was
used as an internal loading control.
Western Blotting of proteins
Protein lysates were made from harvested cell pellets
by resuspending in sodium fluoride (NaF; 50 mM Tris
PH 7.5, 150 mM NaCl, 1% Nonidet P-40, 50 mM NaF)
lysis buffer (10 μL 0.1 M sodium vanadate (NaVO3),
20 μL 50× protease inhibitor, 9 μL of 100 mM phenyl-
methylsulfonyl fluoride (PMSF), 1 μLo f1MD T Tp e r
1 ml NaF base buffer). Samples were incubated on ice
for 30 min and then centrifuged at 14,000 rpm for 20
min. Protein concentrations were determined using the
Bradford assay (5X Bradford Reagent, Biorad). Subse-
quently 35 μg of protein from each sample was pre-
pared for immunoblotting on a 4-12% Bis-Tris
gradient pre-cast gel (Nupage, Invitrogen) on a Novex
immunoblotting module (Invitrogen). The gel was run
at 120 V for 2 hrs on ice and then was transferred to a
PDVF membrane (Immobilon, Millipore) at 35 V for
1.75 hrs in cold room. After transfer, the membrane
was immersed in Ponceau reagent (Sigma) to assess
relative loading among the various lanes. The mem-
brane was blocked in 5% non-fat dry milk in 0.1%
Tween/1X TBS (TBST), incubated with the appropriate
antibodies: Bax (1:4000, sc-493, Santa Cruz Biotechnol-
ogy Inc.), catalase, (1:4000, ab16731, Abcam), p53
(1:1000, sc-126, Santa Cruz Biotechnology Inc.), and
GAPDH (1:4000, ab9485, Abcam). Subsequently the
blots were washed in 0.1% TBST. After the incubation
period in the appropriate horseradish peroxidase-con-
jugated secondary antibodies (GE Healthcare, Amer-
sham), the blots were again washed in 0.1% TBST.
Blots were then exposed to autoradiographic films and
developed with the ECLPlus Western Chemilumines-
cent Detection System (GE Healthcare, Amersham) to
determine levels of protein expression.
Table 2 RT-PCR primers for detecting cDNA transcript
RT-PCR Primers Primer Sequence
Bax forward primer 5’ CCCGAGAGGTCTTTTTCCGAG 3’
Bax reverse primer 5’ CCAGCCCATGATGGTTCTGAT 3’
Catalase forward primer 5’ CGCAGAAAGCTGATGTCCTGA 3’
Catalase reverse primer 5’ TCATGTGTGACCTCAAAGTAGC 3’
p53 forward primer 5’ GAGGTTGGCTCTGACTGTACC 3’
p53 reverse primer 5’ TCCGTCCCAGTAGATTACCAC 3’
GAPDH forward primer 5’ GACCCCTTCATTGACCTCAAC 3’
GAPDH reverse primer 5’ CTTCTCCATGGTGGTGAAGA 3’
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Additional file 1: Figure S1. Map of pBLIC-neo. The LIC adaptor is
annotated at bases 1361-1386 with the sequencing primers used to
verify insertion noted within the diagram. The BamHI and PmlI sites are
also noted. The actual sequence around the LIC adaptor site is shown
below the map, with key elements highlighted (see Figure 1 for
additional details). Figure S2. Sequencing verification of pBLIC.Bax, pBLIC.
catalase and pBLIC.p53 constructs. Positive clones (screened by restriction
digestion in Figure 3) were sequenced at the Oncogenomics Core
facility, University of Miami, FL. The sequences presented here were
analyzed using the BLAST algorithm at the NCBI website and found to
be accurate. Start and stop codons are highlighted in red text. (A) Bax
sequence. Please note that a single A -> G base mismatch (underlined)
corresponds to a UCA to UCG silent codon mutation as both sequences
encode for serine. (B) Catalase sequences. A small portion consisting of
74 bases was not covered by the catalase primer sets; however the
presence of start and stop codons in conjunction with the RT-PCR and
Western blot data presented in Figure 4 verify that the full cDNA was
successfully cloned within pBLIC-neo. (C) p53 sequences.
Abbreviations
LIC: ligation-independent cloning; MMLV: Moloney murine leukemia virus;
RT-PCR: reverse transcriptase polymerase chain reaction.
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